Modarres M - Search Results

1

Transscleral diode laser photocoagulation for type 1 prethreshold retinopathy of prematurity.

Parvaresh MM, Ghasemi Falavarjani K, Modarres M, Nazari H, Saiepour N. Parvaresh MM, et al. Among authors: modarres m. J Ophthalmic Vis Res. 2013 Oct;8(4):298-302. J Ophthalmic Vis Res. 2013. PMID: 24653815 Free PMC article.

2

Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity.

Parvaresh MM, Modarres M, Falavarjani KG, Sadeghi K, Hammami P. Parvaresh MM, et al. Among authors: modarres m. J AAPOS. 2009 Dec;13(6):535-8. doi: 10.1016/j.jaapos.2009.09.018. J AAPOS. 2009. PMID: 20006811

3

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Nazari H, Modarres M, Parvaresh MM, Ghasemi Falavarjani K. Nazari H, et al. Among authors: modarres m. Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1713-8. doi: 10.1007/s00417-010-1430-x. Epub 2010 Jun 27. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20582706

4

Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review.

Ghasemi Falavarjani K, Parvaresh MM, Modarres M, Hashemi M, Samiy N. Ghasemi Falavarjani K, et al. Among authors: modarres m. J Ophthalmic Vis Res. 2012 Jul;7(3):235-9. J Ophthalmic Vis Res. 2012. PMID: 23264866 Free PMC article.

5

Pars plana vitrectomy and intravitreal phacoemulsification for dropped nuclei.

Ghasemi Falavarjani K, Hashemi M, Jalili Fazel A, Modarres M, Nazari H, Parvaresh MM. Ghasemi Falavarjani K, et al. Among authors: modarres m. J Ophthalmic Vis Res. 2012 Apr;7(2):125-9. J Ophthalmic Vis Res. 2012. PMID: 23275820 Free PMC article.

6

Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran.

Nazari Khanamiri H, Ghasemi Falavarjani K, Sanati MH, Aryan H, Irani A, Hashemi M, Modarres M, Parvaresh MM, Nikeghbali A. Nazari Khanamiri H, et al. Among authors: modarres m. J Ophthalmic Vis Res. 2014 Apr;9(2):181-7. J Ophthalmic Vis Res. 2014. PMID: 25279119 Free PMC article.

7

Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD.

Modarres M, Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Parvaresh MM. Modarres M, et al. Retina. 2009 Mar;29(3):319-24. doi: 10.1097/IAE.0b013e318198148e. Retina. 2009. PMID: 19287288 Clinical Trial.

8

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.

Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM. Modarres M, et al. Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52. doi: 10.1177/112067210901900526. Eur J Ophthalmol. 2009. PMID: 19787608 Clinical Trial.

9

Vitrectomy for posterior segment intraocular foreign bodies, visual and anatomical outcomes.

Falavarjani KG, Hashemi M, Modarres M, Parvaresh MM, Naseripour M, Nazari H, Fazel AJ. Falavarjani KG, et al. Among authors: modarres m. Middle East Afr J Ophthalmol. 2013 Jul-Sep;20(3):244-7. doi: 10.4103/0974-9233.114803. Middle East Afr J Ophthalmol. 2013. PMID: 24014990 Free PMC article.

10

Accidental subretinal injection of triamcinolone acetonide.

Modarres M, Parvaresh MM, Peyman GA. Modarres M, et al. Ophthalmic Surg Lasers. 1998 Nov;29(11):935-8. Ophthalmic Surg Lasers. 1998. PMID: 9824868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters